⌕
Burning Rock Biotech · BNR · Nasdaq
Tenet 42 · Weak
Compare
$13.32+1.91%At closeTenet 42 · Weak
$13.32+0.25 (+1.91%)
At close: Nov 19, 2026, 4:00 PM ET· Nasdaq · USD

Burning Rock Biotech (BNR) Stock

Burning Rock Biotech (BNR) closed at $13.32 on Nov 19, 2026; its Tenet Score is 42 of 100 against 341 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

36 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$13.32
Nov 19, 2026
52-week range
6.79 – 41.72
low → high · as of close, Nov 19, 2026
Tenet Score
42/100
Weak · 341 Healthcare peers

Industry: Health Services

Burning Rock Biotech Ltd scores 42/100. Weak. Growth is the soft spot versus 341 Healthcare peers. Insufficient inputs: Tenet 42 is built from 3 of 4 pillars, from 50% of its inputs. The pillars showing a dash had no data.

Tenet Score · vs sector

n=341
42/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
—
Quality
47
Health
57
Growth
22

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Value omitted — no data yet.
Value—QualityDHealthCGrowthFMomentumF
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
—
Withheld by our checks.
P/S
—
Withheld by our checks.
ROE
−10%
fiscal year to Dec 31, 2025
Operating margin
−10.2%
before interest and tax
Net margin
−10.3%
fiscal year to Dec 31, 2025
Current ratio
2.99
fiscal year to Dec 31, 2025
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Market cap
—
no market cap on file
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Burning Rock Biotech Ltd

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. The company primarily offers 12 next-generation sequencing-based cancer therapy selection tests applicable to a range of cancer ty…

Composite computed Nov 19, 2026 · peer basis: Healthcare (n=341) · every glimpse links to its full section with sources · not investment advice.

What sector and industry is Burning Rock Biotech in?

Burning Rock Biotech is in the Healthcare sector and the Health Services industry.

What is Burning Rock Biotech's Tenet Score?

Burning Rock Biotech's Tenet Score is 42 out of 100, ranked against 341 Healthcare peers as of Nov 19, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.